NASDAQ$XWEL

XpresSpa Group Inc · Q2 2024 earnings

Q2 2024 earnings · · Investor relations

Briefing

Reported second quarter 2024 results, showing increased revenue and reduced operating and net losses.

XWELL, Inc. reported a revenue increase to $9.3 million compared to $8.2 million in the second quarter of 2023. The company also reduced its operating loss to $1.9 million from $4.7 million and net loss to $2.0 million from $5.7 million year-over-year. The company continues to focus on strategic growth and cost reduction.

  • Total revenue increased to $9.3 million from $8.2 million in the second quarter of 2023.
  • Operating loss decreased to $1.9 million from $4.7 million year-over-year.
  • Net loss attributable to XWELL decreased to $2.0 million from $5.7 million year-over-year.
  • The company is focused on balancing its portfolio with growth outside the airport and cost-effectively integrating innovative services.

Headline financials

Total Revenue

$9.28M

Previous: $8.18M+13.5%
EPS

-$0.48

Previous: -$1.40+65.7%
Total operating expenses

$5M

No prior period
General and administrative

$4.7M

No prior period
Capital Expenditures

-$644K

Previous: -$1.24M+47.9%
Free Cash Flow

-$2.64M

Previous: -$6.97M+62.1%
Net Income

-$2M

Previous: -$5.73M+65.2%
Operating Income

-$1.89M

Previous: -$4.72M+59.9%
Gross Profit

$3.08M

Previous: $1.19M+158.7%
Stock-Based Comp

$304K

Previous: $626K-51.4%

Revenue & EPS history

XpresSpa · Revenue · Quarterly

$9.28M

Q2 2024+13.5%vs Q2 2023
Beat estimate in 3 of 10 quarters(30%)
ActualEstimate

Revenue by segment

XpresSpa · $6.64M total across 3 segments · Q1 2026

  • XpresSpa
    $4.2M
  • XpresTest
    $1.92M
  • Naples Wax
    $524K

Forward guidance

The company remains focused on continuous improvement across its business and extending its collaboration with the CDC for its traveler-based SARS-CoV-2 Genomic Surveillance program.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q2 2024

Historical avgQ2 2024

+1.1%

Avg return

Earnings day

-2.3%

Avg return

5 days after

-4.5%

Avg return

30 days after

43%

16 / 37 earnings

Positive

+24.4%

Q4 2019

Best reaction

-11.1%

Q4 2017

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026
Q3 2025+0.0%-8.4%-9.6%
Q2 2025-5.8%-8.3%-8.3%
Q1 2025+1.2%+12.8%+9.3%
Q4 2024+0.0%+0.0%+15.4%
Q3 2024-1.2%-10.6%-24.1%
Q2 2024+3.7%+0.5%-14.8%
Q1 2024+3.4%-8.4%+41.6%
Q4 2023+0.0%+0.7%+32.1%
Q3 2023+6.2%+35.4%+31.1%
Q2 2023-4.2%-4.2%-25.0%
Q1 2023+0.0%+4.2%+4.2%
Q4 2022+6.3%-9.4%-21.9%
Q3 2022+0.0%-12.3%-10.5%
Q2 2022-6.5%-5.4%+9.7%
Q1 2022-1.1%-18.7%-22.0%
Q4 2021+8.2%+52.0%+11.2%
Q3 2021+11.7%+13.1%+25.5%
Q2 2021-6.9%-13.1%-2.9%
Q4 2020+6.4%-3.5%-20.8%
Q3 2020-1.1%-13.4%-22.5%
Q2 2020-6.5%-4.2%-42.9%
Q1 2020-7.5%-5.5%+6.5%
Q4 2019+24.4%+26.8%+17.1%
Q3 2019+2.0%-5.9%-41.6%
Q2 2019+0.0%+21.2%+31.9%
Q1 2019+7.8%-9.0%-40.0%
Q4 2018+0.3%-12.0%-22.7%
Q3 2018+0.0%+0.0%+11.1%
Q2 2018+0.0%-25.0%-20.0%
Q1 2018-4.8%-31.7%-20.6%
Q4 2017-11.1%-24.7%-17.3%
Q3 2017-0.8%-4.0%-6.5%
Q2 2017+11.5%+4.4%+9.7%
Q1 2017+4.9%+1.9%+5.6%
Q4 2016+0.9%-9.7%-20.8%
Q3 2016+0.8%-8.0%-15.6%
Q2 2016-1.9%-1.0%+1.9%
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013
Q3 2013
Q2 2013
Q1 2013
Q4 2012
Q3 2012
Q2 2012
Q1 2012
Q4 2011
Q3 2011

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro